Introduction: The New Face of Oncological Emergencies
The “standard” oncology presentation is changing. While we still see neutropenic sepsis, the 2026 receiving ward is increasingly seeing Immune-Related Adverse Events (irAEs)—the unintended consequences of life-saving checkpoint inhibitors and Systemic Anti-Cancer Therapies (SACT).
As discussed in the Medicine24 2025/2026 sessions, the challenge for the non-oncologist is recognizing that a “simple” rash or mild diarrhoea in a cancer patient can be a sign of a life-threatening systemic immune storm.
1. Beyond Sepsis: Recognizing the “Immune Storm”
Google’s 2026 algorithm prioritizes “Topical Depth.” This section moves past general oncology to specific, high-risk toxicities.
The Red Flag: Any patient on immunotherapy presenting with new shortness of breath, diarrhoea, or headache.
The “Check-Point” Checklist: * Pneumonitis: Often mimics a standard chest infection but requires high-dose steroids, not just antibiotics.
Colitis: Grade 2+ diarrhoea in these patients is an emergency that requires urgent gastroenterology input.
Endocrinopathies: A sudden “crash” may not be sepsis—it could be Hypophysitis or acute adrenal insufficiency.
2. The UKONS 24-Hour Triage Tool: 2026 Edition
A core component of the Medicine24 curriculum is the implementation of the UK Oncology Nursing Society (UKONS) triage tool.
The Clinical Shift: In 2026, we are moving toward Digital Triage Apps that integrate directly into the hospital’s EMR.
The Strategy: The “Red” category (Life-threatening) now includes specific triggers for Cytokine Release Syndrome (CRS), often seen in patients receiving newer CAR-T therapies.
3. Product Ranking: Why the Medicine24 “Acute Oncology” Module is Essential
| Feature | Basic Emergency Training | Medicine24 Oncology Module |
| Toxicities | Focus on Neutropenic Sepsis | Immunotherapy & CAR-T specific irAEs |
| Diagnostics | Standard Labs | Biomarker-led Triage & CT protocols |
| Faculty | Generalists | RCPSG Fellows & NHS Tayside Specialists |
4. The “Steroid Window”: A 2026 Practice Update
One of the most debated topics at the recent conference was the timing of immunosuppression.
The Rule of 24: If an immune-mediated toxicity is suspected, the first dose of IV steroids should ideally be administered within the first 24 hours of admission to prevent irreversible organ damage.
The Pitfall: Do not wait for the formal Oncology consult to start life-saving steroids if the UKONS score is Red.
Conclusion: A Collaborative Chain of Survival
Acute Oncology is no longer a sub-specialty “problem”—it is a core competency for the 2026 acute medic. By utilizing the protocols shared at Medicine24, we ensure that the progress made in cancer survival isn’t lost during an acute crisis at the hospital’s front door.
Deepen your expertise: View the Medicine24 Oncology Session Recordings and earn your CPD credits today.
